EXPERIMENTAL INTRAOCULAR PROLIFERATION AND NEOVASCULARIZATION

被引:36
|
作者
OPHIR, A
BLUMENKRANZ, MS
CLAFLIN, AJ
机构
[1] BASCOM PALMER EYE INST,DEPT OPHTHALMOL,POB 016880,MIAMI,FL 33101
[2] UNIV MIAMI,SCH MED,DEPT SURG,MIAMI,FL 33152
关键词
D O I
10.1016/0002-9394(82)90238-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:450 / 457
页数:8
相关论文
共 50 条
  • [41] HISTOPATHOLOGY OF EXPERIMENTAL PRERETINAL NEOVASCULARIZATION
    DEJUAN, E
    HUMAYUN, MS
    HATCHELL, DL
    WILSON, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1989, 30 (07) : 1495 - 1503
  • [43] EXPERIMENTAL INTRAOCULAR HEMOLYSIS
    BINDER, RF
    GERRAS, T
    MILTHALER, C
    WAHL, SC
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1964, 58 (06) : 945 - &
  • [44] EXPERIMENTAL INTRAOCULAR HEMOLYSIS
    BINDER, RF
    GERRAS, T
    MILTHALER, C
    WAHL, SC
    INVESTIGATIVE OPHTHALMOLOGY, 1964, 3 (04): : 471 - 471
  • [45] EXPERIMENTAL INTRAOCULAR VENOGRAPHY
    COHAN, BE
    ARCHIVES OF OPHTHALMOLOGY, 1960, 63 (03) : 489 - 502
  • [46] EXPERIMENTAL INTRAOCULAR NOCARDIOSIS
    DAYAL, Y
    NEELKANTA, R
    SOOD, NN
    MAHAJAN, VM
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1976, 11 (02): : 155 - 159
  • [47] Systemically expressed soluble Tie2 inhibits intraocular neovascularization
    Hangai, M
    Moon, YS
    Kitaya, N
    Chan, CK
    Wu, DY
    Peters, KG
    Ryan, SJ
    Hinton, DR
    HUMAN GENE THERAPY, 2001, 12 (10) : 1311 - 1321
  • [48] SUBRETINAL NEOVASCULARIZATION FOLLOWING METALLIC INTRAOCULAR FOREIGN-BODY TRAUMA
    TRIMBLE, SN
    SCHATZ, H
    ARCHIVES OF OPHTHALMOLOGY, 1986, 104 (04) : 515 - 519
  • [49] Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks
    Lommatzsch, A.
    Spital, G.
    Trieschmann, M.
    Pauleikhoff, D.
    OPHTHALMOLOGE, 2007, 104 (04): : 325 - 328
  • [50] Inhibition of retinal neovascularization by intraocular gene delivery of soluble VEGF receptors
    Scaria, A
    Pechan, P
    Lukason, M
    Rubin, H
    Wadsworth, S
    MOLECULAR THERAPY, 2004, 9 : S198 - S198